0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 18
  • 7
  • 6
  • 5
  • 3
  • 2
  • 2

PRICE

2
2
37
43

PUBLISHED

0
2
23
43

PRODUCT TYPE

41
2

Search for: "Cytokinetics Inc.-Therapeutic Competitors"

43 Products

Cytokinetics, Inc. (CYTK) - Financial and Strategic SWOT Analysis Review

Cytokinetics, Inc. (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by...

Published:  April 2015
Price:  From

Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review

Cytokinetics, Inc (CYTK) - Financial and Strategic SWOT Analysis Review Summary Cytokinetics, Inc (Cytokinetics) is a clinical stage biopharmaceutical company involved in the discovery and development...

Published:  September 2011
Price:  From

Myasthenia Gravis - Pipeline Review, H1 2014

Myasthenia Gravis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H1 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This...

Published:  June 2014
Price:  From

Myasthenia Gravis - Pipeline Review, H2 2014

Myasthenia Gravis - Pipeline Review, H2 2014 Summary This, ‘Myasthenia Gravis - Pipeline Review, H2 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

Published:  December 2014
Price:  From

Sarcopenia - Pipeline Review, H2 2014

Sarcopenia - Pipeline Review, H2 2014 Summary This, ‘Sarcopenia - Pipeline Review, H2 2014’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides comprehensive information...

Published:  October 2014
Price:  From

Sarcopenia - Pipeline Review, H1 2015

Sarcopenia - Pipeline Review, H1 2015 Summary This, ‘Sarcopenia - Pipeline Review, H1 2015’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides comprehensive information...

Published:  January 2015
Price:  From

Sarcopenia - Pipeline Review, H1 2014

Sarcopenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sarcopenia - Pipeline Review, H1 2014’, provides an overview of the Sarcopenia’s therapeutic pipeline. This report provides...

Published:  April 2014
Price:  From

Myasthenia Gravis - Pipeline Review, H1 2015

Myasthenia Gravis - Pipeline Review, H1 2015 Summary This, ‘Myasthenia Gravis - Pipeline Review, H1 2015’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Cachexia - Pipeline Review, H1 2014

Cachexia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cachexia - Pipeline Review, H1 2014’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive...

Published:  March 2014
Price:  From

Intermittent Claudication - Pipeline Review, H1 2014

Intermittent Claudication - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Intermittent Claudication - Pipeline Review, H1 2014’, provides an overview of the Intermittent Claudication’s...

Published:  June 2014
Price:  From

Cachexia - Pipeline Review, H2 2014

Cachexia - Pipeline Review, H2 2014 Summary This, ‘Cachexia - Pipeline Review, H2 2014’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive information...

Published:  August 2014
Price:  From

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary This, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic...

Published:  January 2015
Price:  From

Pulmonary Hypertension - Pipeline Review, H1 2015

Pulmonary Hypertension - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Hypertension’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

Intermittent Claudication - Pipeline Review, H1 2015

Intermittent Claudication - Pipeline Review, H1 2015 Summary This, ‘Intermittent Claudication - Pipeline Review, H1 2015’, provides an overview of the Intermittent Claudication’s therapeutic pipeline. This...

Published:  January 2015
Price:  From

Intermittent Claudication - Pipeline Review, H2 2014

Intermittent Claudication - Pipeline Review, H2 2014 Summary This, ‘Intermittent Claudication - Pipeline Review, H2 2014’, provides an overview of the Intermittent Claudication’s therapeutic pipeline. This...

Published:  December 2014
Price:  From

Pulmonary Arterial Hypertension - Pipeline Review, H1 2015

Pulmonary Arterial Hypertension - Pipeline Review, H1 2015 Summary This, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Arterial Hypertension’s...

Published:  March 2015
Price:  From

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

Published:  March 2015
Price:  From

Pulmonary Arterial Hypertension - Pipeline Review, H2 2014

Pulmonary Arterial Hypertension - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Arterial Hypertension - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Arterial Hypertension’s...

Published:  October 2014
Price:  From

Cachexia - Pipeline Review, H1 2015

Cachexia - Pipeline Review, H1 2015 Summary This, ‘Cachexia - Pipeline Review, H1 2015’, provides an overview of the Cachexia’s therapeutic pipeline. This report provides comprehensive information...

Published:  January 2015
Price:  From

Hypertension - Pipeline Review, H1 2015

Hypertension - Pipeline Review, H1 2015 Summary the, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • Innocent Drinks Ltd.
  • Groupe Danone
  • Cisco Systems, Inc.
  • The World Bank Group
  • Swarovski AG
  • Owens Corning Corporation
  • Swiss Reinsurance Company Ltd.